Replies to post #30479 on Lexaria Bioscience Corp (LEXX)

[MasterBidder]

That’d have been nice quote in the PR

[AgentSmith]

I hate to say this, but, what is it then that they're going to go to the "big institutional investors" with... this!?

- We've announced logarithmic growth in our CBD B2B business line; (who hasn't...?)
- We're working on our first ever antiviral drug delivery study, to learn if our tech could be applicable in that multi-billion $ sector;
- We've announced a larger human clinical follow-up study to test for blood pressure reduction in human hypertensive volunteers. The annual hypertension drug market is a $24 billion opportunity;
- And, we've announced that a tobacco company roughly 50% larger than ALtria, British American Tobacco, is currently evaluating our technology for their own purposes.

I've had my reservations about Chicken-Little'ing the repercussions of the Altria decision from the standpoint of Lexaria's future and DehydraTECH's applicability; but, I do fear Lexaria may not be bringing much to the "big boys'/girls' table" - without that deal in hand - now when it comes time to uplist. :/

Hoping they've got something else up their sleeve...

[harlem111]

thanks Kevin eom